Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Lieberman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|October 8, 2016
Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemiaJie Wang, Jennifer Morrissette, David B Lieberman, et al.
Leukemia|August 9, 2018
Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32Daria V Babushok, Natasha L Stanley, Jennifer J D Morrissette, et al.
Plos One|April 5, 2016
Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene TestingMatthew C Hiemenz, Stephan Kadauke, David B Lieberman, et al.
Haematologica|June 27, 2015
NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic featuresMarlise R Luskin, Auris O Huen, Sarah A Brooks, et al.
Journal of Visualized Experiments : Jove|September 30, 2016
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid TumorsAlan J Fox, Matthew C Hiemenz, David B Lieberman, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Cancer Genetics|December 17, 2018
Validation of a next-generation sequencing oncology panel optimized for low input DNARobyn T Sussman, Sydney Shaffer, Elizabeth M Azzato, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Molecular Genetics & Genomic Medicine|July 29, 2016
A novel approach for next-generation sequencing of circulating tumor cellsStephanie S Yee, David B Lieberman, Tatiana Blanchard, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|October 8, 2016
Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemiaJie Wang, Jennifer Morrissette, David B Lieberman, et al.
Leukemia|August 9, 2018
Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32Daria V Babushok, Natasha L Stanley, Jennifer J D Morrissette, et al.
Plos One|April 5, 2016
Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene TestingMatthew C Hiemenz, Stephan Kadauke, David B Lieberman, et al.
Haematologica|June 27, 2015
NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic featuresMarlise R Luskin, Auris O Huen, Sarah A Brooks, et al.
Journal of Visualized Experiments : Jove|September 30, 2016
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid TumorsAlan J Fox, Matthew C Hiemenz, David B Lieberman, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Cancer Genetics|December 17, 2018
Validation of a next-generation sequencing oncology panel optimized for low input DNARobyn T Sussman, Sydney Shaffer, Elizabeth M Azzato, et al.
Academic Pathology|June 18, 2019
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P Nasrallah, Zev A Binder, Derek A Oldridge, et al.
Molecular Genetics & Genomic Medicine|July 29, 2016
A novel approach for next-generation sequencing of circulating tumor cellsStephanie S Yee, David B Lieberman, Tatiana Blanchard, et al.
Leukemia|July 1, 2021
Germline POT1 variants can predispose to myeloid and lymphoid neoplasmsTristan L Lim, David B Lieberman, Adam R Davis, et al.
Pageof 2